partial AUCs for locally acting MR [Design Issues]

posted by Kumarnaidu2 – India, 2021-05-28 11:55 (23 d 20:41 ago) – Posting: # 22375
Views: 225

Hi all,

Recently we have conducted a pilot BE study of Mesalamine granules 4g. Partial AUCs (AUC0-12 and AUC12-t) were one of the primary parameters as this is for EMA. In this study AUC12-t parameter was not calculated as the concentrations after 12 were BLQ for almost all subjects except one or two subjects. what would be the possible reason for this?

Some solutions suggested by experts include
1) lowering the LLOQ range 2) Increase the dosage (but don't know the highest acceptable dose in healthy volunteer studies).

Any advice and suggestions will be a great help.

Thanks in advance


Complete thread:

 Admin contact
21,530 posts in 4,499 threads, 1,524 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Monday 08:37 CEST (Europe/Vienna)

Young man, in mathematics you don’t understand things.
You just get used to them.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz